442 related articles for article (PubMed ID: 18602217)
1. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.
Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G
Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217
[TBL] [Abstract][Full Text] [Related]
2. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
3. N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.
Okine BN; Madasu MK; McGowan F; Prendergast C; Gaspar JC; Harhen B; Roche M; Finn DP
Pain; 2016 Dec; 157(12):2687-2696. PubMed ID: 27649266
[TBL] [Abstract][Full Text] [Related]
4. Spinal anandamide produces analgesia in neuropathic rats: possible CB(1)- and TRPV1-mediated mechanisms.
Starowicz K; Makuch W; Osikowicz M; Piscitelli F; Petrosino S; Di Marzo V; Przewlocka B
Neuropharmacology; 2012 Mar; 62(4):1746-55. PubMed ID: 22178705
[TBL] [Abstract][Full Text] [Related]
5. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
6. Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors.
Maione S; De Petrocellis L; de Novellis V; Moriello AS; Petrosino S; Palazzo E; Rossi FS; Woodward DF; Di Marzo V
Br J Pharmacol; 2007 Mar; 150(6):766-81. PubMed ID: 17279090
[TBL] [Abstract][Full Text] [Related]
7. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
[TBL] [Abstract][Full Text] [Related]
8. The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy.
Wallace VC; Segerdahl AR; Lambert DM; Vandevoorde S; Blackbeard J; Pheby T; Hasnie F; Rice AS
Br J Pharmacol; 2007 Aug; 151(7):1117-28. PubMed ID: 17558434
[TBL] [Abstract][Full Text] [Related]
9. Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide.
Bettoni I; Comelli F; Colombo A; Bonfanti P; Costa B
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):34-44. PubMed ID: 23394519
[TBL] [Abstract][Full Text] [Related]
10. Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.
D'Agostino G; La Rana G; Russo R; Sasso O; Iacono A; Esposito E; Mattace Raso G; Cuzzocrea S; Loverme J; Piomelli D; Meli R; Calignano A
Eur J Pharmacol; 2009 Jun; 613(1-3):54-9. PubMed ID: 19386271
[TBL] [Abstract][Full Text] [Related]
11. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
[TBL] [Abstract][Full Text] [Related]
12. Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma.
Paterniti I; Impellizzeri D; Crupi R; Morabito R; Campolo M; Esposito E; Cuzzocrea S
J Neuroinflammation; 2013 Feb; 10():20. PubMed ID: 23374874
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors.
Farquhar-Smith WP; Jaggar SI; Rice AS
Pain; 2002 May; 97(1-2):11-21. PubMed ID: 12031775
[TBL] [Abstract][Full Text] [Related]
14. Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats.
De Filippis D; Luongo L; Cipriano M; Palazzo E; Cinelli MP; de Novellis V; Maione S; Iuvone T
Mol Pain; 2011 Jan; 7():3. PubMed ID: 21219627
[TBL] [Abstract][Full Text] [Related]
15. Ultramicronized Palmitoylethanolamide and Paracetamol, a New Association to Relieve Hyperalgesia and Pain in a Sciatic Nerve Injury Model in Rat.
Peritore AF; Siracusa R; Fusco R; Gugliandolo E; D'Amico R; Cordaro M; Crupi R; Genovese T; Impellizzeri D; Cuzzocrea S; Di Paola R
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429243
[TBL] [Abstract][Full Text] [Related]
16. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
[TBL] [Abstract][Full Text] [Related]
17. Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models.
Sasso O; Moreno-Sanz G; Martucci C; Realini N; Dionisi M; Mengatto L; Duranti A; Tarozzo G; Tarzia G; Mor M; Bertorelli R; Reggiani A; Piomelli D
Pain; 2013 Mar; 154(3):350-360. PubMed ID: 23218523
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.
Helyes Z; Németh J; Thán M; Bölcskei K; Pintér E; Szolcsányi J
Life Sci; 2003 Sep; 73(18):2345-53. PubMed ID: 12941436
[TBL] [Abstract][Full Text] [Related]
20. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G
Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
